- Use Bifidobacteria based DDS as a development platform with the aim of meeting unmet medical needs
- Through joint support alongside private sector venture capital aim to generate domestic drug discovery success stories
Our Portfolio
Anaeropharma Science Inc.
| Outline | Biopharma company aiming to launch a new drug in cooperation with the pharmaceutical industry, with the Drug Delivery System (DDS) developed by Shinshu University as its core |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Venture company |
Provided Support
| Authorized Investment | ¥4.2 billion (maximum) |
|---|---|
| Investment Structure |